Trials / Active Not Recruiting
Active Not RecruitingNCT06996912
A Study for HSK44459 in Participants With Atopic Dermatitis
A Phase 2 Study Investigating the Efficacy and Safety of HSK44459 Tablet Administered to Participants With Atopic Dermatitis
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Xizang Haisco Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy and safety of HSK44459 in adults with Atopic Dermatitis
Detailed description
This is a multicenter, randomized, double-blind, parallel group, placebo controlled phase 2 study to assess the efficacy and safety of HSK44459 in adult participants with Atopic Dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HSK44459 | HSK44459 will be administered orally twice daily |
| DRUG | Placebo | Placebo will be administered orally twice daily |
Timeline
- Start date
- 2025-05-22
- Primary completion
- 2026-01-20
- Completion
- 2026-03-23
- First posted
- 2025-05-30
- Last updated
- 2026-01-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06996912. Inclusion in this directory is not an endorsement.